Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 8 studies | 25% ± 8% | |
interneuron | 6 studies | 32% ± 20% | |
endothelial cell | 5 studies | 25% ± 12% | |
GABAergic neuron | 5 studies | 34% ± 15% | |
epithelial cell | 4 studies | 31% ± 3% | |
endothelial cell of lymphatic vessel | 4 studies | 23% ± 4% | |
neuron | 3 studies | 25% ± 7% | |
glutamatergic neuron | 3 studies | 44% ± 8% | |
type I pneumocyte | 3 studies | 21% ± 5% | |
basal cell | 3 studies | 23% ± 8% | |
transit amplifying cell | 3 studies | 26% ± 12% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 35% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 2903.70 | 245 / 245 | 100% | 19.96 | 502 / 502 |
esophagus | 100% | 1795.12 | 1443 / 1445 | 100% | 12.28 | 183 / 183 |
thymus | 100% | 3632.90 | 653 / 653 | 100% | 17.66 | 603 / 605 |
pancreas | 100% | 5159.03 | 328 / 328 | 99% | 14.23 | 176 / 178 |
kidney | 100% | 2788.19 | 89 / 89 | 99% | 22.40 | 889 / 901 |
bladder | 100% | 2342.86 | 21 / 21 | 98% | 11.81 | 496 / 504 |
breast | 99% | 2151.78 | 454 / 459 | 99% | 16.37 | 1112 / 1118 |
stomach | 100% | 2258.30 | 358 / 359 | 99% | 12.33 | 282 / 286 |
lung | 99% | 1758.04 | 574 / 578 | 99% | 10.94 | 1140 / 1155 |
intestine | 100% | 1965.31 | 962 / 966 | 98% | 12.76 | 518 / 527 |
ovary | 100% | 3578.44 | 180 / 180 | 98% | 10.21 | 420 / 430 |
uterus | 100% | 2373.48 | 170 / 170 | 97% | 11.10 | 447 / 459 |
adrenal gland | 98% | 1615.19 | 254 / 258 | 93% | 12.80 | 215 / 230 |
brain | 94% | 1534.70 | 2495 / 2642 | 91% | 7.01 | 643 / 705 |
liver | 98% | 1123.62 | 222 / 226 | 86% | 7.78 | 351 / 406 |
skin | 99% | 1378.48 | 1788 / 1809 | 67% | 4.97 | 318 / 472 |
spleen | 100% | 1936.14 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 9.33 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.75 | 1 / 1 |
blood vessel | 99% | 1692.35 | 1328 / 1335 | 0% | 0 | 0 / 0 |
adipose | 98% | 1135.81 | 1179 / 1204 | 0% | 0 | 0 / 0 |
heart | 87% | 751.45 | 752 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 5.38 | 25 / 29 |
eye | 0% | 0 | 0 / 0 | 81% | 8.05 | 65 / 80 |
muscle | 80% | 574.90 | 644 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 63% | 653.70 | 588 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZNF33B |
Protein name | Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2) ZNF33B protein Zinc finger protein 33B |
Synonyms | ZNF11B KOX2 |
Description | FUNCTION: May be involved in transcriptional regulation. |
Accessions | A0A087WXF4 A0A087X1D4 ENST00000359467.8 Q06732 ENST00000493285.2 A0A087WXT3 A0A087WVA3 ENST00000465206.5 ENST00000462075.1 Q3B799 Q6P1A4 ENST00000613419.4 |